Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
aFGF combined with artificial dermis for full-thickness skin defect wounds
ChiCTR2400088353Phase 4Recruiting
- Sponsor
- Central Hospital Affiliated to Shandong First Medical University
- Start
- Aug 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of fibroblast growth factor 1 (2 arms), sponsored by Central Hospital Affiliated to Shandong First Medical University. Primary endpoint: Grafting interval time. Started Aug 2024; status: recruiting.
02
Drugs
fibroblast growth factor 1
Beyond the preview
Go deeper on ChiCTR2400088353.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400088353.